Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Company: XERS Direction: Sold

Company

Date

Insider

Role

Action ?

Shares

Amount

Of holding

XERS Xeris Biopharma Holdings, Inc.

1 Sep 2026

See Remarks

Sold on a plan

16,666

$141.43K

1.5%

XERS Xeris Biopharma Holdings, Inc.

1 Sep 2026

McCulloch Kevin

See Remarks

Sold on a plan

15,000

$127.31K

0.9%

XERS Xeris Biopharma Holdings, Inc.

1 Sep 2026

See Remarks

Sold on a plan

5,000

$42.50K

0.4%

XERS Xeris Biopharma Holdings, Inc.

12 Aug 2026

See Remarks

Sold on a plan

5,000

$42.50K

0.4%

XERS Xeris Biopharma Holdings, Inc.

3 Aug 2026

See Remarks

Sold on a plan

16,666

$133.55K

1.4%

XERS Xeris Biopharma Holdings, Inc.

3 Aug 2026

McCulloch Kevin

See Remarks

Sold on a plan

15,000

$120.24K

0.9%

XERS Xeris Biopharma Holdings, Inc.

7 Jul 2026

See Remarks

Sold on a plan

27,600

$235.28K

2.0%

XERS Xeris Biopharma Holdings, Inc.

6 Jul 2026

See Remarks

Sold on a plan

17,400

$147.90K

1.2%

XERS Xeris Biopharma Holdings, Inc.

1 Jul 2026

McCulloch Kevin

See Remarks

Sold on a plan

90,000

$722.51K

5.1%

XERS Xeris Biopharma Holdings, Inc.

1 Jul 2026

See Remarks

Sold on a plan

16,666

$133.86K

1.4%

XERS Xeris Biopharma Holdings, Inc.

4 Jun 2026

Director

Sold on a plan

20,000

$121.89K

17.4%

XERS Xeris Biopharma Holdings, Inc.

4 Jun 2026

BORMANN-KENNEDY BARBARA-JEAN ANNE

Director

Sold on a plan

16,000

$97.51K

11.2%

XERS Xeris Biopharma Holdings, Inc.

4 Jun 2026

Director

Sold on a plan

15,000

$91.42K

2.1%

XERS Xeris Biopharma Holdings, Inc.

3 Jun 2026

Director

Sold on a plan

15,500

$91.43K

10.9%

XERS Xeris Biopharma Holdings, Inc.

1 Jun 2026

See Remarks

Sold on a plan

16,667

$100.98K

1.4%

XERS Xeris Biopharma Holdings, Inc.

1 May 2026

See Remarks

Sold on a plan

16,667

$103.81K

1.4%

XERS Xeris Biopharma Holdings, Inc.

1 Apr 2026

See Remarks

Sold on a plan

16,667

$99.86K

1.4%

XERS Xeris Biopharma Holdings, Inc.

30 Mar 2026

Brady James Aloysius

Director

Sold on a plan

10,834

$60.04K

10.8%

XERS Xeris Biopharma Holdings, Inc.

2 Mar 2026

See Remarks

Sold on a plan 2×

16,667

$104.09K

1.3%

XERS Xeris Biopharma Holdings, Inc.

2 Feb 2026

See Remarks

Sold at will

16,667

$124.15K

1.3%

XERS Xeris Biopharma Holdings, Inc.

8 Jan 2026

McCulloch Kevin

See Remarks

Sold on a plan

15,000

$120.00K

0.9%

XERS Xeris Biopharma Holdings, Inc.

5 Jan 2026

Shannon John Patrick Jr

See Remarks

Sold at will

24,907

$176.26K

0.9%

XERS Xeris Biopharma Holdings, Inc.

2 Jan 2026

See Remarks

Sold on a plan

16,667

$123.78K

1.3%

XERS Xeris Biopharma Holdings, Inc.

19 Dec 2025

Director

Sold at will

135,400

$977.02K

16.2%

XERS Xeris Biopharma Holdings, Inc.

12 Dec 2025

BORMANN-KENNEDY BARBARA-JEAN ANNE

Director

Sold on a plan

15,000

$106.41K

9.5%

XERS Xeris Biopharma Holdings, Inc.

1 Dec 2025

See Remarks

Sold on a plan

16,667

$116.78K

1.2%

XERS Xeris Biopharma Holdings, Inc.

13 Nov 2025

Shannon John Patrick Jr

See Remarks

Sold at will

23,242

$173.40K

0.9%

XERS Xeris Biopharma Holdings, Inc.

11 Nov 2025

See Remarks

Sold on a plan

16,667

$123.30K

1.2%

XERS Xeris Biopharma Holdings, Inc.

11 Sep 2025

Director

Sold on a plan

15,500

$119.61K

9.8%

XERS Xeris Biopharma Holdings, Inc.

28 Aug 2025

SHERMAN JEFFREY W

Director

Sold at will

42,232

$334.52K

16.2%

XERS Xeris Biopharma Holdings, Inc.

13 Aug 2025

Director

Sold at will

107,500

$786.46K

11.4%

XERS Xeris Biopharma Holdings, Inc.

12 Aug 2025

Director

Sold at will

42,500

$309.23K

27.0%

XERS Xeris Biopharma Holdings, Inc.

20 Mar 2025

See Remarks

Sold at will

40,000

$217.24K

2.9%

XERS Xeris Biopharma Holdings, Inc.

22 Feb 2022

PRESTRELSKI STEVEN

Chief Scientific Officer

Sold, plan not stated

11,228

$27.16K

1.9%

Showing 1–34 of 34.